HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

Creatine

HCID 586
New noteNew reactionRequest quotes
Print preview

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
57-00-1
Standard SMILES
CN(CC(=O)O)C(=N)N
InChIKey
CVSVTCORWBXHQV-UHFFFAOYSA-N
Molecular formula
C4H9N3O2
Average molar mass
131.13 g/mol
Monoisotopic mass
131.06947654

Overview

Creatine is a glycine derivative having methyl and amidino groups attached to the nitrogen. It has a role as a geroprotector, a nutraceutical, a neuroprotective agent, a mouse metabolite and a human metabolite. It is a glycine derivative and a member of guanidines. It is a conjugate acid of a creatinate. It is a tautomer of a creatine zwitterion.

Names & identifiers

Preferred name
Creatine
IUPAC
2-[carbamimidoyl(methyl)amino]acetic acid
English name
Creatine
Molecular formula
C4H9N3O2
Molecular weight
131.13

Names & synonyms

creatine57-00-1CreatinN-amidinosarcosineKreatinKrebiozonmethylglycocyamineN-methyl-N-guanylglycineGlycine, N-(aminoiminomethyl)-N-methyl-Pyrolysate(alpha-Methylguanido)acetic acidN-carbamimidoyl-N-methylglycine
Show more names
N-GUANYL-N-METHYLGLYCINEMONOHYDRATE CREATINEN-Methyl-N-amidinoglycinecretineCreatine HMBCreatineAnhydrousNutrition Creatinecreatine zwitterion
Cosmocair C 100KreatinumNeotine2-(1-methylcarbamimidamido)acetic acidN-(aminoiminomethyl)-N-methylglycinealpha-Methylguanidino acetic acid2-[carbamimidoyl(methyl)amino]acetic acidNSC-8752

Database identifiers

CAS
57-00-1、6020-87-7
PubChem CID
586
DTXSID
DTXSID1040451
ChEMBL
CHEMBL283800
ChEBI

Properties

Computed structural propertiesFilling in

XLogP
-1.2
Topological polar surface area
90.4 Ų
Hydrogen bond donors
3
Hydrogen bond acceptors
3
Rotatable bonds
3
Heavy atoms
9
Formal charge
0
Complexity
134

Experimental & physicochemical properties

Chemical ClassesBiological Agents -> Amino Acids and Derivatives
DrugsPharmaceuticals -> Listed in ZINC15
pHNeutral reaction to litmus
Density1.33 at 25 °C
Solubility · 4 items

Slightly soluble in water, insoluble in ether

Slightly soluble in ether and ethanol

In water, 1.33X10+4 mg/L at 18 °C

13.3 mg/mL at 18 °C

Dietary IngredientsCreatine
Human DrugsBreast Feeding; Lactation; Milk, Human; Amino Acids; Complementary Therapies
Melting Point · 2 items

Decomposes at 303 °C

303 °C

Vapor Pressure0.00079 [mmHg]
Physical Description · 2 items

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 5 items

This chemical does not meet GHS hazard criteria for 72.3% (149 of 206) of all reports.

Warning

H315 (27.7%): Causes skin irritation [Warning Skin corrosion/irritation]

P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 206 reports by companies from 13 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory Information · 4 items

Chemical: Glycine, N-(aminoiminomethyl)-N-methyl-

REACH registered substance: N-amidinosarcosine (EC: 200-306-6)

Glycine, N-(aminoiminomethyl)-N-methyl-: Does not have an individual approval but may be used under an appropriate group standard

Creatine: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationEvaluation - Chemicals that are unlikely to require further regulation to manage risks to environment
Hazards SummaryA skin and strong eye irritant; [Alfa Aesar MSDS]
Hazard Classes and CategoriesSkin Irrit. 2 (27.7%)

Safety & protection

Disposal Methods · 1 item

SRP: The most favorable course of action is to use an alternative chemical product with less inherent propensity for occupational exposure or environmental contamination. Recycle any unused portion of the material for its approved use or return it to the manufacturer or supplier. Ultimate disposal of the chemical must consider: the material's impact on air quality; potential migration in soil or water; effects on animal, aquatic, and plant life; and conformance with environmental and public health regulations.

Chemistry & industry

Pharmacology

Bionecessity · 1 item

Creatine is a non-protein amino acid found in animals, in much lesser amounts, plants. Creatine is synthesized in the kidney, liver and pancreas from the amino acids L-arginine, glycine and L methionine. Following its biosynthesis, creatine is transported to the skeletal muscle, heart, brain and other tissues. Most of the creatine in these tissues is metabolized to phosphocreatine (creatine phosphate). Phosphocreatine is a major energy storage form in the body.

Pharmacodynamics · 1 item

Creatine is a essential, non-proteinaceous amino acid derivative found in all animals. It is synthesized in the kidney, liver, and pancreas from L-arginine, glycine and L-methionine. Following its biosynthesis, creatine is transported to the skeletal muscle, heart, brain and other tissues. Most of the creatine is metabolized in these tissues to phosphocreatine (creatine phosphate). Phosphocreatine is a major energy storage form in the body. Supplemental creatine may have an energy-generating action during anaerobic exercise and may also have neuroprotective and cardioprotective actions.

Mechanism of Action · 3 items

In the muscles, a fraction of the total creatine binds to phosphate - forming creatine phosphate. The reaction is catalysed by creatine kinase, and the result is phosphocreatine (PCr). Phosphocreatine binds with adenosine diphosphate to convert it back to ATP (adenosine triphosphate), an important cellular energy source for short term ATP needs prior to oxidative phosphorylation.

Supplemental creatine may have an energy-generating action during anaerobic exercise and may also have neuroprotective and cardioprotective actions.

Creatine, creatine kinase and phosphocreatine make up an intricate cellular enegy buffering and transport system connecting sites of energy production in the mitochondria with sites of energy consumption. CK is a key enzyme in involved in cellular energy homeostasis. It reversibly catalyzes the transfer of the high-energy phosphate bond in PCr to adenosine diphosphate (ADP) to form adenosine triphosphate (ATP), and it catalyzes the transfer of the high-energy phosphate bond in ATP to creatine to form PCr. During periods of intense exercise and skeletal muscle contraction, bioenergetic metabolism switches from one in which oxidative phosphorylation is the major pathway of ATP production to one in which so-called anaerobic glycolysis becomes dominant.

Related reactions

58 records
New reaction record
HRID 93167 reaction equation
HRID 93167As productAs reactantTraining data from https://doi.org/10.1039/C8SC04228D (2/10)
HRID 363829 reaction equation
HRID 363829As reactantuspto-grants-1999_02
HRID 482702 reaction equation
HRID 482702As reactantuspto-grants-1986_03
HRID 501921 reaction equation
HRID 501921As reactantuspto-grants-2010_08
HRID 504078 reaction equation
HRID 504078As reactantuspto-grants-2010_08
HRID 613450 reaction equation
HRID 613450As productAs reactantuspto-grants-1999_12
HRID 815164 reaction equation
HRID 815164As productAs reactantTest data from https://doi.org/10.1039/C8SC04228D
HRID 821248 reaction equation
HRID 821248As reactantTest data from https://doi.org/10.1039/C8SC04228D
Page 1 of 8

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes
CHEBI:16919
UNII
MU72812GK0
EC Number
200-306-6
Nikkaji
J9.321A

Solid; [Merck Index] White powder; [Alfa Aesar MSDS]

Solid

Dissociation Constants · 2 items

pKa1 = 3.8 (carboxylic acid); pKa2 = 12.7 (amine)

pKb = 11.02 at 20 °C

Collision Cross Section · 4 items

126.0 Ų [M+H]+ [CCS Type: DT; Buffer gas: N2; Ionization: ESI+; Dataset: TOXCAST; Source Identifier: DTXSID1040451]

126 Ų [M+H]+ [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]

125.9 Ų [M+H]+ [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]

126 Ų [M+H]+

Physicochemical properties

Melting point
295 °C · ~295 °C (dec.)
Boiling point
242.43 °C · 242.43°C (rough estimate)
Density
1 · 1,33 g/cm3
refractive index
1.57 · 1.5700 (estimate)
storage temp.
Keep in dark place,Inert atmosphere,Room temperature
solubility
Water (Slightly, Heated)
form
Solid
pka
2.63 · 2.63(at 25℃)
color
White to Off-White
Water Solubility
Soluble in water.
Merck
14 · 14,2568
BRN
907175 · 907175
Major Application
food and beveragespersonal carepharmaceutical
Cosmetics Ingredients Functions
SKIN CONDITIONING
InChI
1S/C4H9N3O2/c1-7(4(5)6)2-3(8)9/h2H2,1H3,(H3,5,6)(H,8,9)
InChIKey
CVSVTCORWBXHQV-UHFFFAOYSA-N
SMILES
CN(CC(O)=O)C(N)=N
LogP
-1.258 · -1.258 (est)
CAS DataBase Reference
57 · 57-00-1(CAS DataBase Reference)
EWG's Food Scores
1 · 1
NCI Dictionary of Cancer Terms
creatine
FDA UNII
72812 GK0 · MU72812GK0
NIST Chemistry Reference
Glycine, N-(aminoiminomethyl)-N-methyl-(57-00-1)
EPA Substance Registry System
Glycine, N-(aminoiminomethyl)-N-methyl- (57-00-1)
UNSPSC Code
12352209 · 12352209
NACRES
26 · NA.26
CAS Number Unlabeled
57 · 57-00-1
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
315 · H315-H319-H335
Precautionary statements
261 · P261-P280a-P304+P340-P305+P351+P338-P405-P501a
Hazard Codes
Xi
Risk Statements
36 · 36/37/38
Safety Statements
26 · 26-36
WGK Germany
3 · 3
TSCA
TSCA listed
HS Code
29252900 · 29252900
Storage Class
11 · 11 - Combustible Solids
Hazardous Substances Data
57 · 57-00-1(Hazardous Substances Data)
Toxicity
A compound that is phosphorylated to phosphocreatine, which represents a store of high-energy phosphoryl groups in muscle that can be transferred to ADP, yielding ATP for muscle contraction. The enzyme involved in phosphate transfer between them is creatine phosphokinase that catalyzes the reaction Phosphocreatine+ADP→ATP+creatine An increase in serum creatine phosphokinase may be indicative of damage to non-hepatic tissue but not to the liver.
REACH Registrations
Active

Toxicology

Body Burden · 1 item

The mean creatine level in the urine of 50 patients with muscular dystrophy was 3.56 mmol/L which is much higher than that of the controls 0.24 mmol/L(1). The mean level of creatine in the blood of patients with uremia was 0.1 mmol/L which is over twice that of the controls blood level of 0.04 mmol/L(1).

Environmental Fate · 3 items

TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 24(SRC), determined from a water solubility of 1.33X10+4 mg/L(2) and a regression-derived equation(3), indicates that creatine is expected to have very high mobility in soil(SRC). The pKa values for the amino and carboxylic acid moieties of creatine are estimated to be 12.7 and 3.8(4), respectively, indicating that this compound will primarily exist as a zwitter ion and zwitter ions do not volatilize from moist soil surfaces. Creatine is not expected to volatilize from dry soil surfaces(SRC) based upon an estimated vapor pressure of 7.9X10-4 mm Hg(SRC), determined from a fragment constant method(5). Creatine has been reported to be degraded by activated sludge(6).

AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 24(SRC), determined from a water solubility of 1.33X10+4 mg/L(2) and a regression-derived equation(3), indicates that creatine is not expected to adsorb to suspended solids and sediment(SRC). The pKa values for the amino and carboxylic acid moieties of creatine are estimated to be 12.7 and 3.8, respectively(4), indicating that this compound will primarily exist as a zwitter ion and zwitter ions do not volatilize from water surfaces. According to a classification scheme(5), an estimated BCF of 3(SRC), determined from its water solubility(2) and a regression-derived equation(3), suggests the potential for bioconcentration in aquatic organisms is low(SRC). Creatine has been shown to be degraded by activated sludge(7).

ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), creatine, which has an estimated vapor pressure of 7.9X10-4 mm Hg at 25 °C(SRC), determined from a fragment constant method(2), will exist solely in the vapor phase in the atmosphere. Vapor-phase creatine is degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals(SRC); the half-life for this reaction in air is estimated to be 4 hours(SRC), calculated from its rate constant of 9.5x10-11 cu cm/molecule-sec at 25 °C(SRC) that was derived using a structure estimation method(3). Creatine does not absorb light at wavelengths >290 nm(4) and therefore is not expected to be susceptible to direct photolysis by sunlight(SRC).

Toxicity Summary · 1 item

In the muscles, a fraction of the total creatine binds to phosphate - forming creatine phosphate. The reaction is catalysed by creatine kinase, and the result is phosphocreatine (PCr). Phosphocreatine binds with adenosine diphosphate to convert it back to ATP (adenosine triphosphate), an important cellular energy source for short term ATP needs prior to oxidative phosphorylation.

Soil Adsorption/Mobility · 1 item

The Koc of creatine is estimated as 24(SRC), using a water solubility of 1.33X10+4 mg/L(1) and a regression-derived equation(2). According to a classification scheme(3), this estimated Koc value suggests that creatine is expected to have very high mobility in soil.

Natural Pollution SourcesCreatine is produced by the liver, pancreas, and kidney for the use of transferring phosphate from adenosine triphosphate (ATP). Creatine is predominantly found in skeletal and cardiac muscle(1).
Artificial Pollution SourcesCreatine's production and use as a diagnostic for myocardial disfunction(1) and as a performance enhancing supplement(2) may result in its release to the environment through various waste streams(SRC).
Environmental Biodegradation · 2 items

AEROBIC: Creatine has been reported to be aerobically degraded by activated sludge(1).

ANAEROBIC: Creatine, at a concn of 500 umol/10 ml, was fermented into methane by methanogenic enrichment cultures from Leine River mud (lake Kolksee, Germany) and black pond mud, containing Methanosarcina barkeri(1). Creatine was fermented into methane with an efficiency of 1.59 moles of methane/mole of creatine(1). Creatine did not support growth of a pure culture of M. barkeri(1).

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Environmental Bioconcentration · 1 item

An estimated BCF of 3 was calculated for creatine(SRC), using water solubility of 1.33X10+4 mg/L(1) and a regression-derived equation(2). According to a classification scheme(3), this BCF suggests the potential for bioconcentration in aquatic organisms is low.

Volatilization from Water/Soil · 1 item

The pKa values of the amino and carboxy moieties of creatine are 12.7 and 3.8(1), respectively, indicating that this compound will primarily exist as a zwitter ion and ions do not volatilize from water or moist soil surfaces. Creatine is not expected to volatilize from dry soil surfaces(SRC) based upon an estimated vapor pressure of 7.9X10-4 mm Hg(SRC), determined from a fragment constant method(2).

Non-Human Toxicity Excerpts/LABORATORY ANIMALS: Chronic Exposure or Carcinogenicity/ Chronic creatine supplementation in rats down-regulates creatine transporter protein expression. ... Leading to lower amounts entering cell at any given time.
Environmental Abiotic Degradation · 1 item

The rate constant for the vapor-phase reaction of creatine with photochemically-produced hydroxyl radicals has been estimated as 9.5X10-11 cu cm/molecule-sec at 25 °C(SRC) using a structure estimation method(1). This corresponds to an atmospheric half-life of about 4 hours at an atmospheric concentration of 5X10+5 hydroxyl radicals per cu cm(1). Creatine is not expected to undergo hydrolysis in the environment due to the lack of hydrolyzable functional groups(2). Creatine does not absorb at wavelengths >290 nm(3) and therefore is not expected to be susceptible to direct photolysis by sunlight(SRC).

Safety data

wgk
3
tsca
TSCA listed
hs_code
29252900
Toxicity
A compound that is phosphorylated to phosphocreatine, which represents a store of high-energy phosphoryl groups in muscle that can be transferred to ADP, yielding ATP for muscle contraction. The enzyme involved in phosphate transfer between them is creatine phosphokinase that catalyzes the reaction Phosphocreatine+ADP→ATP+creatine An increase in serum creatine phosphokinase may be indicative of damage to non-hepatic tissue but not to the liver.
risk_code
36/37/38
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xi
safety_code
26-36
Storage Class
11 - Combustible Solids
Hazard statements
H315-H319-H335
REACH Registrations
Active
Precautionary statements
P261-P280a-P304+P340-P305+P351+P338-P405-P501a
Hazardous Substances Data
57-00-1(Hazardous Substances Data)
Biological Half-Life3 hours
Metabolism/Metabolites · 2 items

Within muscle and nerve cells, about 60 to 67% of the creatine entering the cells gets converted to phosphocreatine via the enzyme creatine kinase. About 2% of creatine is converted to creatinine, and both creatine and creatinine are excreted by the kidneys.

Half Life: 3 hours

Absorption, Distribution and Excretion · 2 items

In muscle and nerve, most of the creatine is phosphorylated to phosphocreatine (pCr) in a reaction that is catalyzed by the enezyme creatine kinase (CK), there are three isoforms of (isoenzymes) of CK. CK-MM is the skeletal muscle isoform; CK-BB, the brain isoform, and CK-MB, the isoform found in cardiac muscle. Most of the PCr in the body is in skeletal muscle.

Creatine is absorbed from the small intestines and enters the portal circulation and is transported to the liver. The ingested creatine, and the creatine made in the liver, is then transported into the systemic circulation and distributed into various tissues of the body, including muscle and nerves, by crossing the cell membrane via a specific creatine-transported system against a 200:1 gradient.

Tissue LocationsAdipose Tissue
Cellular LocationsCytoplasm
Metabolite Pathways3-Phosphoglycerate dehydrogenase deficiency

Uses & manufacturing

Uses · 3 items

An amino acid found mainly in skeletal and cardiac muscle; Involved in the transfer of high energy phosphate in muscle cells; [Merck Index] Used in the diagnosis of myocardial dysfunction and as a dietary supplement to enhance athletic performance; [HSDB]

Used in diagnosis of myocardial disfunction; dietary supplement for exercise performance

For nutritional supplementation, also for treating dietary shortage or imbalance

Methods of ManufacturingMonosubstituted and N,N-disubstituted compounds, including guanidinocarboxylic acids (eg, creatine), are produced industrially by the reaction of cyanamide with the corresponding amines or aminocarboxylic acids.
Household ProductsInformation on 3 consumer products that contain Creatine in the following categories is provided:
General Manufacturing Information · 3 items

Glycine, N-(aminoiminomethyl)-N-methyl-: ACTIVE

The literature suggests that some pharmaceutically active compounds originating from human and veterinary therapy are not eliminated completely in municipal sewage treatment plants and are therefore discharged into receiving waters(1). Wastewater treatment processes often were not designed to remove them from the effluent(2). Selected organic waste compounds may be degrading to new and more persistent compounds that may be released instead of or in addition to the parent compound(2).

Commercially isolated from meat extracts

Applications · 4 items

Uses1. It can be used as the nutritional supplements for promoting the adaptation of skeletal muscle to strenuous exercise and fighting against the excessive fatigue for feeble individuals. 2. It can be used as the drugs for the treatment of heart disease and respiratory insufficiency. 3. It can be used for preparation of a pharmaceutical formulation containing human growth hormone. 4. It can be applied to compound health food with anti-aging and physical-power recovering effect. 5. It can be used as the reagents for biochemical research.

OccurrenceCreatine is an amino acid that occurs naturally in dairy products, seafood, and beef. It is manufactured by the body in the liver, kidney, and pancreas.

UsesCreatine is used for gyrate atrophy, McArdle's disease, muscular dystrophy, amyotrophic lateral sclerosis, and rheumatoid arthritis. It is used in congestive heart disease to improve exercise tolerance and to enhance athletic performance.

UsesCreatine is involved in the rapid production of ATP associated with creatine kinases in skeletal muscle tissue. Creatine may be used as a supplement to study its mechanism of action. It acts as a nutraceutical and a neuroprotective agent.

Upstream & downstream products

Downstream products

Polyinosinic acid-polycytidylic acidcorrosion inhibitor HS-13Creatinine2-[5H-CHROMENO[4,3-D]PYRIMIDIN-2-YL(METHYL)AMINO]ACETIC ACID
Additional notes · 1 item

DefinitionChEBI: Creatine is a glycine derivative having methyl and amidino groups attached to the nitrogen. It has a role as a neuroprotective agent, a nutraceutical, a human metabolite, a mouse metabolite and a geroprotector. It is a member of guanidines and a glycine derivative. It is a conjugate acid of a creatinate. It is a tautomer of a creatine zwitterion.